Outcome of children with retinoblastoma and isolated choroidal invasion

Archives of Ophthalmology

Volumn 130, Issue 6, 2012, Pages 724-729

  Bosaleh, Andrea ^a   Sampor, Claudia ^a   Solernou, Verónica ^a   Fandiño, Adriana ^a   Domínguez, Julieta ^a   De Dávila, María T G ^a   Chantada, Guillermo L ^a  

^a HOSPITAL DE PEDIATRÍA PROF DR JUAN P GARRAHAN   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ARTICLE; CANCER GRADING; CANCER PROGNOSIS; CANCER RELAPSE; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; CHOROID METASTASIS; EVENT FREE SURVIVAL; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; ORBIT METASTASIS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRESCHOOL CHILD; PRIORITY JOURNAL; RETINOBLASTOMA; RETROSPECTIVE STUDY; SCHOOL CHILD;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; CHOROID NEOPLASMS; DISEASE-FREE SURVIVAL; EYE ENUCLEATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; MAGNETIC RESONANCE IMAGING; MALE; NEOPLASM GRADING; NEOPLASM INVASIVENESS; RETINAL NEOPLASMS; RETINOBLASTOMA; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84856611132     PISSN: 00039950     EISSN: 15383601     Source Type: Journal    
DOI: 10.1001/archophthalmol.2012.567     Document Type: Article

References (24)

1. Broaddus E, Topham A, Singh AD. Survival with retinoblastoma in the USA: 1975-2004. Br J Ophthalmol. 2009;93(1):24-27.
2. Eagle RC Jr. High-risk features and tumor differentiation in retinoblastoma: a retrospective histopathologic study. Arch Pathol Lab Med. 2009;133(8):1203-1209.
3. Chantada GL, Dunkel IJ, de Dávila MT, Abramson DH. Retinoblastoma patients with high risk ocular pathological features: who needs adjuvant therapy? Br J Ophthalmol. 2004;88(8):1069-1073. (Pubitemid 39013152)
4. Uusitalo MS, Van Quill KR, Scott IU, Matthay KK, Murray TG, O'Brien JM. Evaluation of chemoprophylaxis in patients with unilateral retinoblastoma with high-risk features on histopathologic examination. Arch Ophthalmol. 2001;119(1):41-48. (Pubitemid 32096384)
5. Shields CL, Shields JA, Baez KA, Cater J, De Potter PV. Choroidal invasion of retinoblastoma: metastatic potential and clinical risk factors. Br J Ophthalmol. 1993;77(9):544-548. (Pubitemid 23281450)
6. Honavar SG, Singh AD, Shields CL, et al. Postenucleation adjuvant therapy in high-risk retinoblastoma. Arch Ophthalmol. 2002;120(7):923-931. (Pubitemid 34755545)
7. Howarth C, Meyer D, Hustu HO, Johnson WW, Shanks E, Pratt C. Stage-related combined modality treatment of retinoblastoma: results of a prospective study. Cancer. 1980;45(5):851-858. (Pubitemid 10129832)
8. Khelfaoui F, Validire P, Auperin A, et al. Histopathologic risk factors in retinoblastoma: a retrospective study of 172 patients treated in a single institution. Cancer. 1996;77(6):1206-1213. (Pubitemid 26080915)
9. Stannard C, Lipper S, Sealy R, Sevel D. Retinoblastoma: correlation of invasion of the optic nerve and choroid with prognosis and metastases. Br J Ophthalmol. 1979;63(8):560-570. (Pubitemid 9211220)
10. Gupta R, Vemuganti GK, Reddy VA, Honavar SG. Histopathologic risk factors in retinoblastoma in India. Arch Pathol Lab Med. 2009;133(8):1210-1214.
11. Kopelman JE, McLean IW, Rosenberg SH. Multivariate analysis of risk factors for metastasis in retinoblastoma treated by enucleation. Ophthalmology. 1987;94(4):371-377. (Pubitemid 17056025)
12. Rubin CM, Robison LL, Cameron JD, et al. Intraocular retinoblastoma group V: an analysis of prognostic factors. J Clin Oncol. 1985;3(5):680-685. (Pubitemid 15119241)
13. Chantada GL, Doz F, Orjuela M, et al International Retinoblastoma Staging Working Group. World disparities in risk definition and management of retinoblastoma: a report from the International Retinoblastoma Staging Working Group. Pediatr Blood Cancer. 2008;50(3):692-694. (Pubitemid 351155863)
14. Sastre X, Chantada GL, Doz F, et al International Retinoblastoma Staging Working Group. Proceedings of the consensus meetings from the International Retinoblastoma Staging Working Group on the pathology guidelines for the examination of enucleated eyes and evaluation of prognostic risk factors in retinoblastoma. Arch Pathol Lab Med. 2009;133(8):1199-1202.
15. Schvartzman E, Chantada G, Fandiño A, de Dávila MT, Raslawski E, Manzitti J. Results of a stage-based protocol for the treatment of retinoblastoma. J Clin Oncol. 1996;14(5):1532-1536. (Pubitemid 26134210)
16. Chantada G, Fandiño A, de Dávila MT, et al. Results of a prospective study for the treatment of retinoblastoma. Cancer. 2004;100(4):834-842. (Pubitemid 38176864)
17. Chantada GL, Fandiño AC, Guitter MR, et al. Results of a prospective study for the treatment of unilateral retinoblastoma. Pediatr Blood Cancer. 2010;55(1):60-66.
18. Chantada GL, Casco F, Fandiño AC, et al. Outcome of patients with retinoblastoma and postlaminar optic nerve invasion. Ophthalmology. 2007;114(11):2083-2089. (Pubitemid 350016354)
19. Chantada GL, Fandiño AC, Raslawski EC, et al. Experience with chemoreduction and focal therapy for intraocular retinoblastoma in a developing country. Pediatr Blood Cancer. 2005;44(5):455-460. (Pubitemid 40614493)
20. Walker RW, Rosenblum MK, Kempin SJ, Christian MC. Carboplatin-associated thrombotic microangiopathic hemolytic anemia. Cancer. 1989;64(5):1017-1020. (Pubitemid 19208850)
21. Finger PT, Harbour JW, Murphree AL, et al. Retinoblastoma. New York, NY: Springer; 2010.
22. Palma J, Sasso DF, Dufort G, et al. Successful treatment of metastatic retinoblastoma with high-dose chemotherapy and autologous stem cell rescue in South America [published online ahead of print May 23, 2011]. Bone Marrow Transplant. doi:10.1038/bmt.2011.108.
23. Schmidt P, Haas RJ, Göbel U, Calaminus G. Results of the German studies (MAHO) for treatment of testicular germ cell tumors in children - an update. Klin Padiatr. 2002;214(4):167-172. (Pubitemid 34925492)
24. Naseripour M, Nazari H, Bakhtiari P, Modarres-zadeh M, Vosough P, Ausari M. Retinoblastoma in Iran: outcomes in terms of patients' survival and globe survival. Br J Ophthalmol. 2009;93(1):28-32.